कोशिश गोल्ड - मुक्त

Tata, Kalyani unlikely to tie up with HAL for Amca race; L&T picks BEL

Business Standard

|

September 25, 2025

Tata Advanced Systems (TASL) and Kalyani group are leaning towards not tying up with state-owned Hindustan Aeronautics (HAL) as they prepare to qualify for developing the prototype of India’s first indigenous stealth fighter jet — the Advanced Medium Combat Aircraft (Amca), sources told Business Standard.

- BHASWAR KUMAR

Tata, Kalyani unlikely to tie up with HAL for Amca race; L&T picks BEL

Full-scale model of the Advanced Medium Combat Aircraft, which was showcased at the 15th edition of Aero India in Bengaluru from February 10 to 14, 2025

(PIB)

Tata Advanced Systems (TASL) and Kalyani group are leaning towards not tying up with state-owned Hindustan Aeronautics (HAL) as they prepare to qualify for developing the prototype of India’s first indigenous stealth fighter jet — the Advanced Medium Combat Aircraft (Amca), sources told Business Standard.

With Larsen & Toubro (L&T) on Wednesday announcing its tieup with state-run Bharat Electronics (BEL), sources added that the only other very large private-sector players who remain potential candidates for a tieup with HAL are Adani group and Mahindra group. The government intends the Amca programme to serve as a pathway for setting up a parallel fighter jet production line.

Highlighting that a substantial number of private companies have approached HAL, sources said that the twoor three-party consortium (the maximum permitted) that HAL is expected to lead in pursuing the Amca programme could take one of two forms. Either the defence public sector undertaking (DPSU) will team up with one of the four or five largest private firms still in play alongside a smaller company, or it may choose to tie up entirely with smaller players — with the likes of Dynamatic Technologies and VEM Technologies being likely candidates in that category. In response to an emailed query, HAL declined to comment on the matter.

Business Standard से और कहानियाँ

Business Standard

Labour Codes impact: HCL tech profit slips 11%

Q3 top line beats Street estimates, bottom line misses expectations

time to read

2 mins

January 13, 2026

Business Standard

New labour Codes, restructuring weigh on TCS earnings

Tata Consultancy Services (TCS), India’s largest information technology (IT) services firm, saw its profit impacted in the October-December quarter by restructuring and changes in labour Codes.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Black drives the thrill for car buyers

Sees a surge in yearly sales, while white remains practical 'utility king'

time to read

2 mins

January 13, 2026

Business Standard

CHOOSING THE RIGHT B-SCHOOL TO MATCH YOUR CAREER GOALS

Success comes when you pick an institution that fits your professional dreams and your personality, helping you become the leader you want to be

time to read

2 mins

January 13, 2026

Business Standard

Business Standard

China’s PVC rethink to help India pipe makers

Supply likely to tighten after S-PVC rebate withdrawal

time to read

2 mins

January 13, 2026

Business Standard

Responsible growth

India must ensure data centres are sustainable

time to read

2 mins

January 13, 2026

Business Standard

India’s GenZ is full of creativity: PM

Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.

time to read

1 min

January 13, 2026

Business Standard

Business Standard

Iran wants to negotiate after threats to attack, says Trump

At least 572 killed in protests; Tehran says situation ‘under full control’

time to read

2 mins

January 13, 2026

Business Standard

Insurers knock on Irdai door for clarity on director overlap ban

CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY

time to read

2 mins

January 13, 2026

Business Standard

Delhi HC allows Zydus to sell generic version of cancer drug

Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.

time to read

1 min

January 13, 2026

Listen

Translate

Share

-
+

Change font size